Page last updated: 2024-11-04

succinylacetone and Autoimmune Disease

succinylacetone has been researched along with Autoimmune Disease in 1 studies

succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.

Research Excerpts

ExcerptRelevanceReference
"The effects of succinylacetone (SA) on the development of S-antigen-induced experimental autoimmune uveitis (EAU) in the rat were studied."7.67Treatment of experimental autoimmune uveitis in the rat with systemic succinylacetone. ( Blaese, RM; Hess, RA; Nussenblatt, RB; Palestine, AG; Skolik, SA, 1988)
"The effects of succinylacetone (SA) on the development of S-antigen-induced experimental autoimmune uveitis (EAU) in the rat were studied."3.67Treatment of experimental autoimmune uveitis in the rat with systemic succinylacetone. ( Blaese, RM; Hess, RA; Nussenblatt, RB; Palestine, AG; Skolik, SA, 1988)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Skolik, SA1
Palestine, AG1
Blaese, RM1
Nussenblatt, RB1
Hess, RA1

Other Studies

1 other study available for succinylacetone and Autoimmune Disease

ArticleYear
Treatment of experimental autoimmune uveitis in the rat with systemic succinylacetone.
    Clinical immunology and immunopathology, 1988, Volume: 49, Issue:1

    Topics: Animals; Autoimmune Diseases; Dose-Response Relationship, Drug; Female; Heptanoates; Heptanoic Acids

1988